Condition
Lipidomics
Total Trials
6
Recruiting
4
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Recruiting4
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07225153Not ApplicableRecruiting
Goat Milk-Derived Formula vs. Undiluted Goat Milk in Infants Unable to Exclusively Breastfeed: Growth and Biomarker Analysis
NCT06909006Phase 3Not Yet Recruiting
Semaglutide Treatment in Type 1 Diabetes
NCT04832100Recruiting
Bio-significance of LPC16:0 in Fibromyalgia
NCT06915389Recruiting
Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients
NCT05307367Not ApplicableRecruiting
Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms
NCT03857984Not ApplicableCompleted
Hemodialysis and Erythrocyte Fatty-Acid Status: a Lipidomics Study
Showing all 6 trials